Cover ImageSALE
市場調查報告書

糖尿病管理設備的全球市場:2017年∼2021年

Global Diabetes Management Devices Market 2017-2021

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 582958
出版日期 內容資訊 英文 122 Pages
訂單完成後即時交付
價格
Back to Top
糖尿病管理設備的全球市場:2017年∼2021年 Global Diabetes Management Devices Market 2017-2021
出版日期: 2017年11月16日 內容資訊: 英文 122 Pages
簡介

關於糖尿病管理設備

糖尿病管理裝置包括胰島素輸送系統和血糖監測裝置,用於有效且高效地治療糖尿病,副作用較少。糖尿病(1型和2型)是由於葡萄糖障礙而發生的慢性疾病。導致該疾病的主要因素包括肥胖、城市化、久坐的生活方式、吸煙、膽固醇水平升高和高血壓。這個市場的供應商提供高端的胰島素輸送系統(侵入性小,時尚,袖珍型和便攜式設備)和持續葡萄糖監測系統,這些系統非常高效且具有用戶友好的特性。

Technavio分析師預測,全球糖尿病管理設備市場在2017-2021年期間將以8.08%的複合年成長率成長。

本報告提供全球糖尿病管理設備市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 簡介

  • 市場概要

第5章 市場情形

  • 市場概況
  • 波特的五力分析

第6章 市場區隔:各產品

  • 比較:各產品
  • 胰島素輸送系統
  • 血糖監視設備
  • 市場機會:各產品

第7章 市場劃分:各終端用戶

  • 醫院
  • 專門的糖尿病診療所
  • 居家醫療
  • 其他

第8章 地區情形

  • 地理市場區隔
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 人工胰臟受到高度的關注
  • 居家醫療重點的
  • 技術進步/改善

第12章 供應商情形

  • 競爭模式
  • 主要新聞
  • M&A

第13章 供應商分析

  • 供應商概要
  • Abbott
  • Dexcom
  • F. Hoffmann-La Roche
  • LifeScan
  • Medtronic
  • 其他有力供應商

第14章 附錄

  • 簡稱清單
目錄
Product Code: IRTNTR15766

About Diabetes Management Devices

Diabetes management devices include insulin delivery systems and blood glucose monitoring devices, which are used to treat diabetes effectively and efficiently with fewer side effects. Diabetes (type 1 and type 2) is a chronic disease condition, which occurs due to glucose impairment. The major factors contributing to the disease include obesity, urbanization, sedentary lifestyle, smoking, an elevated level of cholesterols, and hypertension. Vendors in this market are offering high-end insulin delivery systems (less invasive, sleek, pocket-sized, and portable devices) and continuous glucose monitoring systems, which are highly efficient and have user-friendly features.

Technavio's analysts forecast the global diabetes management devices market to grow at a CAGR of 8.08% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global diabetes management devices market for 2017-2021. To calculate the market size, the report considers the sales from insulin delivery systems and continuous blood glucose monitoring systems.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Diabetes Management Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • Dexcom
  • F. Hoffmann-La Roche
  • LifeScan
  • Medtronic

Other Prominent Vendors

  • AgaMatrix
  • Animas
  • ARKRAY
  • Ascensia Diabetes Care
  • B. Braun Melsungen
  • BD
  • Beta Bionics
  • Bigfoot Biomedical
  • BIONIME USA
  • CellNovo
  • Eli Lilly
  • iHealth Labs
  • Insulet
  • Nemaura Medical
  • Nipro
  • Nova Biomedical
  • Novo Nordisk
  • Panasonic Healthcare
  • Prodigy Diabetes Care
  • Sanofi
  • Senseonics
  • Tandem Diabetes Care
  • Trividia Health
  • TypeZero Technologies
  • Valeritas
  • WellDoc

Market driver

  • Rising global burden of diabetes
  • For a full, detailed list, view our report

Market challenge

  • Prohibitive cost of the diabetes care devices
  • For a full, detailed list, view our report

Market trend

  • Growing focus on artificial pancreas
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: INTRODUCTION

  • Market outline

PART 05: MARKET LANDSCAPE

  • Market overview
  • Five forces analysis

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Comparison by product
  • Insulin delivery systems
  • Blood glucose monitoring devices
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY END-USERS

  • Hospitals
  • Specialty diabetes clinics
  • Home care settings
  • Others

PART 08: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Diabetes management devices market in Americas
  • Diabetes management devices market in EMEA
  • Diabetes management devices market in APAC
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing focus on artificial pancreas
  • Increasing focus on home care settings
  • Technological advancements/improvements

PART 12: VENDOR LANDSCAPE

  • Competitive scenario
  • Key news
  • M&A

PART 13: VENDOR ANALYSIS

  • Vendor overview
  • Abbott
  • Dexcom
  • F. Hoffmann-La Roche
  • LifeScan
  • Medtronic
  • Other prominent vendors

PART 14: APPENDIX0

  • List of abbreviations0

List of Exhibits

  • Exhibit 01: Types of diabetes
  • Exhibit 02: Risk factors for diabetes
  • Exhibit 03: Global diabetes management devices market 2016-2021 ($ millions)
  • Exhibit 04: Five forces
  • Exhibit 05: Segmentation of global diabetes management devices by product 2016
  • Exhibit 06: Global diabetes management devices market analysis by product 2016
  • Exhibit 07: Global diabetes management devices market by product 2016 and 2021 (%)
  • Exhibit 08: Global diabetes management devices market by product 2016 and 2021 ($ millions)
  • Exhibit 09: Global diabetes management devices market share by product 2016-2021 (%)
  • Exhibit 10: Comparison by product
  • Exhibit 11: Global insulin delivery systems market 2016-2021 ($ millions)
  • Exhibit 12: Global insulin delivery systems market: Year-over-year (YoY) growth 2017-2021 (%)
  • Exhibit 13: Global blood glucose monitoring devices market 2016-2021 ($ millions)
  • Exhibit 14: Global blood glucose monitoring devices market: YoY growth 2017-2021 (%)
  • Exhibit 15: Global diabetes management devices market: Opportunity by product
  • Exhibit 16: Global diabetes management devices market by end-users 2016 (%)
  • Exhibit 17: Global diabetes management devices market analysis by geography 2016
  • Exhibit 18: Segmentation of global diabetes management devices market by geography 2016 and 2021 ($ millions)
  • Exhibit 19: Segmentation of global diabetes management devices market by geography 2016 and 2021 (%)
  • Exhibit 20: Global diabetes management devices market share by geography 2016-2021 (%)
  • Exhibit 21: Global diabetes management devices market: Regional comparison
  • Exhibit 22: Diabetes management devices market in Americas 2016-2021 ($ millions)
  • Exhibit 23: Diabetes management devices market in Americas: YoY growth 2017-2021 (%)
  • Exhibit 24: Top three countries in Americas
  • Exhibit 25: Diabetes management devices market in EMEA 2016-2021 ($ millions)
  • Exhibit 26: Diabetes management devices market in EMEA: YoY growth 2017-2021 (%)
  • Exhibit 27: Top three countries in EMEA
  • Exhibit 28: Diabetes management devices market in APAC 2016-2021 ($ millions)
  • Exhibit 29: Diabetes management devices market in APAC: YoY growth 2017-2021 (%)
  • Exhibit 30: Top three countries in APAC
  • Exhibit 31: Prevalence of diabetes 2000 and 2030 (millions)
  • Exhibit 32: Recent product launches
  • Exhibit 33: Product recalls
  • Exhibit 34: Pipeline products
  • Exhibit 35: Abbott: Key highlights
  • Exhibit 36: Abbott: Strength assessment
  • Exhibit 37: Abbott: Strategy assessment
  • Exhibit 38: Abbott: Opportunity assessment
  • Exhibit 39: Dexcom: Key highlights
  • Exhibit 40: Dexcom: Strength assessment
  • Exhibit 41: Dexcom: Strategy assessment
  • Exhibit 42: Dexcom: Opportunity assessment
  • Exhibit 43: F. Hoffmann-La Roche: Key highlights
  • Exhibit 44: F. Hoffmann-La Roche: Strength assessment
  • Exhibit 45: F. Hoffmann-La Roche: Strategy assessment
  • Exhibit 46: F. Hoffmann-La Roche: Opportunity assessment
  • Exhibit 47: LifeScan: Key highlights
  • Exhibit 48: LifeScan: Strength assessment
  • Exhibit 49: LifeScan: Strategy assessment
  • Exhibit 50: LifeScan: Opportunity assessment
  • Exhibit 51: Medtronic: Key highlights
  • Exhibit 52: Medtronic: Strength assessment
  • Exhibit 53: Medtronic: Strategy assessment
  • Exhibit 54: Medtronic: Opportunity assessment
Back to Top